Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends that Matter for FDA Regulation

Posted by Matt Breese on Oct 6, 2016

Find me on:

A collection of engaging infographics from healthcare influencers to highlight general trends in FDA approvals and regulation in pharma:

Understanding the designation of pharmaceuticals during the FDA approval process is critical in pharma. Genentech breaks down the various designations, from "breakthrough therapy" to "fast track" and "priority review".

Genentech_FDA_Approval_Designations.jpg 

 

The FDA's breakthrough program is a popular topic when it comes to pharma regulation. The most common therapeutic areas when it comes to breakthrough designations include: oncology, infectious disease, metabolic, neurology and autoimmune, according to Citline.

Snip-breakthrough-infographic2-fda-citeline.png

 

As we all remember, 2015 was a record setting year when it comes to FDA approvals. Nearly 50% of those approvals were for drugs treating rare diseases with an average investment of $2 billion each. Via ALSA.

10-04-16-FDA-Guidance-Infographic-6116.png

 

Subscribe to the MMIT blog for more insights on trends affecting pharmaceutical manufacturers, providers and payers.

Subscribe for Weekly Trends that Matter

Topics: Specialty, Industry Trends, Branding & Marketing